Cetera Advisor Networks LLC Mesoblast LTD Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.09 $89,655 - $152,435	-21,500 Reduced 58.9%	15,000 $72,000
Q3 2021 Nov 16, 2021	BUY	$5.87 - $7.85 $64,570 - $86,350	11,000 Added 43.14%	36,500 $219,000
Q2 2021 Aug 13, 2021	SELL	$6.69 - $9.0 $548,459 - $737,838	-81,982 Reduced 76.28%	25,500 $191,000
Q1 2021 May 17, 2021	BUY	$8.26 - $11.4 $726,731 - $1 Million	87,982 Added 451.19%	107,482 $889,000
Q4 2020 Feb 17, 2021	BUY	$8.21 - $18.59 $57,470 - $130,130	7,000 Added 56.0%	19,500 $166,000
Q3 2020 Nov 13, 2020	SELL	$11.33 - $19.81 $45,320 - $79,240	-4,000 Reduced 24.24%	12,500 $232,000
Q2 2020 Aug 13, 2020	BUY	$4.2 - $15.45 $27,300 - $100,425	6,500 Added 65.0%	16,500 $188,000
Q1 2020 May 08, 2020	BUY	$3.38 - $10.63 $33,800 - $106,300	10,000 New	10,000 $44,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.